Medical News

RSS

Study shows neurobiological mechanisms of how individual risk preferences determine risk perception

Some people live their lives by the motto "no risk - no fun!" and avoid hardly any risks. Others are clearly more cautious and focus primarily on safety when investing and for other business activities. Scientists from the University of Bonn in cooperation with colleagues from the University of Zurich studied the attitudes towards risk in a group of 56 subjects.

26 Nov 2012

Lawmakers return to Washington to face the 'fiscal cliff'

As interest groups ranging from business lobbies to AARP mobilize to protect their constituencies, some Democrats acknowledge that Medicare and Medicaid need to be part of the conversation.

26 Nov 2012

Overexpressed enzyme contributes to development of preeclampsia

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine.

26 Nov 2012

USPTO grants patent for galactomannan-based carbohydrate galectin inhibitor compounds

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for a divisional patent of Patent Number 8,236,780 "Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies".

26 Nov 2012

Two new studies explore how laws, advertising impact cancer costs

Reuters reports on two new studies regarding cancer treatment costs, including findings that laws don't curb the use of pricey prostate cancer treatments and that ads don't increase the use of aromatase inhibitors for breast cancer.

26 Nov 2012

Elsevier announces launch of Leukemia Research Reports journal

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new open access, online journal, Leukemia Research Reports.

26 Nov 2012

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Seattle Genetics, Inc. announced today that ADCETRIS (brentuximab vedotin) has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of mycosis fungoides (MF). MF is the most common type of cutaneous T-cell lymphoma (CTCL).

26 Nov 2012

Pediatricians called to prescribe 'morning-after' pills in advance

Wading into the incendiary subject of birth control for young teenagers, the American Academy of Pediatrics (AAP) on Monday called on the nation's pediatricians to counsel all of their adolescent patients about emergency contraception and make advance prescriptions for it available to girls under 17.

26 Nov 2012

Bruker combines nanoscale AFM zoom capabilities with high-throughput 3D optical microscopy

Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of the unique NanoLens Atomic Force Microscope (AFM) accessory for ContourGT 3D optical microscopes.

From Bruker Nano Surfaces and Metrology 26 Nov 2012

Avermectin family of drugs shows promise against TB

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

26 Nov 2012

Plan to pay less for certain diagnostic tests draws fire

Neurologists in Boston and nationwide are objecting to a plan that would pay them less for certain diagnostic tests, a change meant to cut Medicare costs and direct more money to primary care physicians whose pay is widely seen as inadequate even before they take on more work under the national health care overhaul.

26 Nov 2012

BSD-2000 Hyperthermia System purchased by Cancer Treatment Centers of America

BSD Medical Corporation, a leading provider of medical systems that utilize targeted heat therapy to treat cancer, announced today that the Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (WRMC), located in Goodyear, Arizona, has purchased a BSD-2000 Hyperthermia System (BSD-2000).

26 Nov 2012

Bruker releases new line of IRIS TERS Probes

Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of a new line of IRIS TERS Probes. By enabling Tip-Enhanced Raman Spectroscopy (TERS), the new IRIS TERS probe tips provide users a complete path to non-destructive, label-free chemical detection at the nanoscale.

From Bruker Nano Surfaces and Metrology 26 Nov 2012

Changes in health care deductions soon to kick in

The Wall Street Journal examines key changes in the health insurance marketplace for which consumers should be prepared.

26 Nov 2012

Dicom to introduce DCMSYS router Proxy for medical facilities

Dicom Systems is to unveil a DCMSYS router Proxy, a new feature of its DICOM/HL7 router suite at RSNA meeting this week.

26 Nov 2012

Interim GALAXY Phase 2b lung cancer study results to be presented at APLCC 2012

Synta Pharmaceuticals Corp. announced today that interim results of the Phase 2b portion of the GALAXY program will be presented on November 28, 2012 at 12:15 p.m. (JST) during the "Highlights of Oral Presentations" session at the Fifth Asia Pacific Lung Cancer Conference (APLCC 2012) in Fukuoka City, Japan.

26 Nov 2012

Frankfurt University Hospital implements microwave ablation for treatment of thyroid nodules

The Department of Nuclear Medicine at the Frankfurt University Hospital recently became the first European hospital to use microwaves to ablate thyroid nodules.

26 Nov 2012

Alnylam advances Tuschl II patent estate through the USPTO

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office has issued Notices of Allowance for three patent applications from the company's exclusively held Tuschl II patent estate.

26 Nov 2012

Enrollment complete in Tryton's Pivotal IDE Side Branch Stent trial to treat bifurcation lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.

26 Nov 2012

New Epilepsy & Behavior Case Reports Open Access journal launched by Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of Epilepsy & Behavior Case Reports a new, online-only, Open Access journal devoted to the rapid publication of case reports on the behavioral aspects of seizures and epilepsy. As a sister journal to Epilepsy & Behavior, case reports published in the new journal will benefit from wide exposure and cross-promotion of the two titles.

26 Nov 2012